Fluid retention, joint discomfort, headache Mild edema, joint stiffness, and headaches are commonly reported in the IGF-1 pathway literature, including IGF-1 LR3 community reports
In standard supplemental doses, no
galement disponible en franais SOURCE Health Canada (HC) Media Enquiries: Health Canada, (613) 957-2983, [email protected]

Water/aqua/eau, glycerin, isododecane, cetearyl alcohol, niacinamide, illite, glyceryl stearate, candelilla/jojoba/rice bran polyglyceryl-3 esters, sodium pca, caffeine, hydrogenated polyisobutene, polysilicone-11, lactobacillus ferment, sodium stearoyl lactylate, hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, butylene glycol, polyacrylate crosspolymer-6, synthetic fluorphlogopite, 1,2-hexanediol, caprylyl glycol, lecithin, panthenol, tetrasodium glutamate diacetate, sorbitan isostearate, malus domestica fruit cell culture extract, phenoxyethanol, carbomer, sodium lactate, ceteareth-25, polysorbate 20, caprylic/capric triglyceride, ubiquinone, sodium hyaluronate, potassium sorbate, xanthan gum, acetic acid, acetyl hexapeptide-8, acetyl tetrapeptide-5, ceteareth-6, pterocarpus marsupium bark extract, cyanocobalamin, stearyl alcohol, ethylhexylglycerin, palmitoyl tripeptide-1, palmitoyl tetrapeptide-7, nicotiana benthamiana hexapeptide-40 sh-oligopeptide-1, nicotiana benthamiana octapeptide-30 sh-oligopeptide-2, titanium dioxide (ci 77891) For the latest information, it is recommended to review the ingredient list printed on the packaging of the product prior to usage or consumption

The water trickles down the side of the vial
6 FASEB Journal (PubMed)Active-site mapping of thymosin beta-4 fragments for angiogenesis and cell migration